Paul Brannelly
Overview
Paul Brannelly received an average of $1M in total compensation, including $357K in salary, at Collegium Pharmaceutical from 2015 to 2019. Paul Brannelly also received $2M at Karyopharm Therapeutics in 2013.
- 2019
- 2018
- 2017
- 2016
- 2015
- 2013
Collegium PharmaceuticalExecutive Vice President and Chief Financial Officer
Collegium PharmaceuticalExecutive Vice President and Chief Financial Officer
Collegium PharmaceuticalExecutive Vice President and Chief Financial Officer
Collegium PharmaceuticalExecutive Vice President and Chief Financial Officer
Collegium PharmaceuticalExecutive Vice President and Chief Financial Officer
Karyopharm TherapeuticsSenior Vice President, Finance and Administration
Source: SEC filings on April 9, 2020, March 15, 2019, April 13, 2018, April 13, 2017, and April 28, 2014.
Related executives
We found 19 more executives who work or worked at Collegium Pharmaceutical and Karyopharm Therapeutics.
Richard Paulson
Karyopharm Therapeutics
Chief Executive Officer
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
Michael Mason
Karyopharm Therapeutics
Chief Financial Officer
Jatin Shah
Karyopharm Therapeutics
Chief Medical Officer
Ran Frenkel
Karyopharm Therapeutics
Executive Vice President, Chief Development Officer
Joseph Ciaffoni
Collegium Pharmaceutical
Chief Executive Officer
Richard Malamut
Collegium Pharmaceutical